Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Jan 23;12(2):305.
doi: 10.3390/nu12020305.

The Impact of Coconut Oil and Epigallocatechin Gallate on the Levels of IL-6, Anxiety and Disability in Multiple Sclerosis Patients

Jose Luis Platero  1 , María Cuerda-Ballester  2 , Vanessa Ibáñez  2 , David Sancho  2 , María Mar Lopez-Rodríguez  3 , Eraci Drehmer  4 , Jose Enrique de la Rubia Ortí  2
Affiliations
Randomized Controlled Trial

The Impact of Coconut Oil and Epigallocatechin Gallate on the Levels of IL-6, Anxiety and Disability in Multiple Sclerosis Patients

Jose Luis Platero et al. Nutrients. .

Abstract

Background: Due to the inflammatory nature of multiple sclerosis (MS), interleukin 6 (IL-6) is high in blood levels, and it also increases the levels of anxiety related to functional disability. Epigallocatechin gallate (EGCG) decreases IL-6, which could be enhanced by the anti-inflammatory effect of high ketone bodies after administering coconut oil (both of which are an anxiolytic). Therefore, the aim of this study was to assess the impact of coconut oil and EGCG on the levels of IL-6, anxiety and functional disability in patients with MS.

Methods: A pilot study was conducted for four months with 51 MS patients who were randomly divided into an intervention group and a control group. The intervention group received 800 mg of EGCG and 60 mL of coconut oil, and the control group was prescribed a placebo. Both groups followed the same isocaloric Mediterranean diet. State and trait anxiety were determined before and after the study by means of the State-Trait Anxiety Inventory (STAI). In addition, IL-6 in serum was measured using the ELISA technique and functional capacity was determined with the Expanded Disability Status Scale (EDSS) and the body mass index (BMI).

Results: State anxiety and functional capacity decreased in the intervention group and IL-6 decreased in both groups.

Conclusions: EGCG and coconut oil improve state anxiety and functional capacity. In addition, a decrease in IL-6 is observed in patients with MS, possibly due to the antioxidant capacity of the Mediterranean diet and its impact on improving BMI.

Keywords: anxiety; coconut oil; disability; epigallocatechin gallate; interleukin-6; multiple sclerosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. McFarland H.F., Martin R. Multiple sclerosis: A complicated picture of autoimmunity. Nat. Immunol. 2007;8:913–919. doi: 10.1038/ni1507. - DOI - PubMed
    1. Constantinescu C.S., Gran B. Multiple sclerosis: Autoimmune associations in multiple sclerosis. Nat. Rev. Neurol. 2010;6:591. doi: 10.1038/nrneurol.2010.147. - DOI - PubMed
    1. Kutzelnigg A., Lassmann H. Pathology of multiple sclerosis and related inflammatory demyelinating diseases. Handb. Clin. Neurol. 2014;122:15–58. doi: 10.1016/B978-0-444-52001-2.00002-9. - DOI - PubMed
    1. Stelmasiak Z., Koziol-Montewka M., Dobosz B., Rejdak K., Bartosik-Psujek H., Mitosek-Szewczyk K., Belniak-Legiec E. Interleukin-6 concentration in serum and cerebrospinal fluid in multiple sclerosis patients. Med. Sci. Monit. 2000;6:1104–1108. - PubMed
    1. Bongioanni P., Mosti S., Romano M.R., Lombardo F., Moscato G., Meucci G. Increased T-lymphocyte interleukin-6 binding in patients with multiple sclerosis. Eur. J. Neurol. 2000;7:291–297. doi: 10.1046/j.1468-1331.2000.00075.x. - DOI - PubMed

Publication types

MeSH terms